Ginkgo Bioworks Reports First Quarter 2024 Financial Results [Yahoo! Finance]
Ginkgo Bioworks Holdings, Inc. (DNA)
Company Research
Source: Yahoo! Finance
Initiatives include a reduction of $200 million in annualized run-rate operating expenses by mid-2025, with anticipated substantial reduction occurring in 2024 BOSTON May 9, 2024 /PRNewswire/ -- Ginkgo Bioworks Holdings, Inc. (NYSE: DNA, "Ginkgo"), which is building the leading platform for cell programming and biosecurity, today announced its results for the first quarter ended March 31, 2024 . The update, including a webcast slide presentation with additional details on the first quarter and supplemental financial information, will be available at investors.ginkgobioworks.com First Quarter 2024 Financial Results First quarter 2024 Total revenue of $38 million , down from $81 million in the comparable prior year period, a decrease of 53% primarily driven by the expected ramp down of K-12 testing in Ginkgo's Biosecurity segment First quarter 2024 Cell Engineering revenue of $28 million , down from $34 million in the comparable prior year period, a decrease of 18% driven by a
Show less
Read more
Impact Snapshot
Event Time:
DNA
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
DNA alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
DNA alerts
High impacting Ginkgo Bioworks Holdings, Inc. news events
Weekly update
A roundup of the hottest topics
DNA
News
- Is Ginkgo Bioworks Holdings Stock a Buy? [Yahoo! Finance]Yahoo! Finance
- XWELL, Inc. Reports First Quarter 2024 Results [Yahoo! Finance]Yahoo! Finance
- Ginkgo Bioworks Holdings, Inc. (NYSE: DNA) had its price target lowered by analysts at Morgan Stanley from $2.00 to $1.00. They now have an "equal weight" rating on the stock.MarketBeat
- What's the Difference Between Biotech Stocks and TechBio Stocks? [Yahoo! Finance]Yahoo! Finance
- Ginkgo Bioworks Holdings, Inc. (NYSE: DNA) was downgraded by analysts at BTIG Research from a "neutral" rating to a "sell" rating.MarketBeat
DNA
Earnings
- 5/9/24 - In-Line
DNA
Sec Filings
- 5/20/24 - Form 144
- 5/20/24 - Form EFFECT
- 5/17/24 - Form 424B3
- DNA's page on the SEC website